Pierre Fabre Company Profile
✉ Email this page to a colleague
What is the competitive landscape for PIERRE FABRE, and when can generic versions of PIERRE FABRE drugs launch?
PIERRE FABRE has three approved drugs.
There are two US patents protecting PIERRE FABRE drugs.
There are thirty-nine patent family members on PIERRE FABRE drugs in thirty-one countries.
Summary for Pierre Fabre
International Patents: | 39 |
US Patents: | 2 |
Tradenames: | 3 |
Ingredients: | 3 |
NDAs: | 3 |
Patent Litigation for Pierre Fabre: | See patent lawsuits for Pierre Fabre |
Drugs and US Patents for Pierre Fabre
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pierre Fabre | NAVELBINE | vinorelbine tartrate | INJECTABLE;INJECTION | 020388-001 | Dec 23, 1994 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Pierre Fabre | HEMANGEOL | propranolol hydrochloride | SOLUTION;ORAL | 205410-001 | Mar 14, 2014 | RX | Yes | Yes | 8,338,489 | ⤷ Sign Up | ⤷ Sign Up | ||||
Pierre Fabre | HEMANGEOL | propranolol hydrochloride | SOLUTION;ORAL | 205410-001 | Mar 14, 2014 | RX | Yes | Yes | 8,987,262 | ⤷ Sign Up | ⤷ Sign Up | ||||
Pierre Fabre | ETOPOSIDE | etoposide | INJECTABLE;INJECTION | 074813-001 | Jul 9, 1997 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Pierre Fabre
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Pierre Fabre | NAVELBINE | vinorelbine tartrate | INJECTABLE;INJECTION | 020388-001 | Dec 23, 1994 | 4,307,100*PED | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Pierre Fabre Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Portugal | 2187878 | ⤷ Sign Up |
Poland | 2233135 | ⤷ Sign Up |
China | 102006864 | ⤷ Sign Up |
Slovenia | 2187878 | ⤷ Sign Up |
Portugal | 2233135 | ⤷ Sign Up |
Canada | 2701953 | ⤷ Sign Up |
Chile | 2008003083 | ⤷ Sign Up |
>Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.